Prevalence and Predictors of Complementary Medicine Usage in Diabetes: Fremantle Diabetes Study

Journal of Pharmacy Practice and Research

Volumn 33, Issue 4, 2003, Pages 260-264

  Clifford, Rhonda M ^a   Batty, Kevin T ^a   Davis, Wendy ^b   Davis, Timothy ME ^c  

^a CURTIN UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIUM; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GLUCOSAMINE; MINERAL; MULTIVITAMIN; OMEGA 3 FATTY ACID; VITAMIN; VITAMIN B GROUP;

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; BLOOD GLUCOSE MONITORING; COMORBIDITY; CONSUMER; DIABETES CONTROL; DIABETES MELLITUS; ETHNOLOGY; FEMALE; GENDER; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS MEDIUM; PHARMACIST; PURCHASING; STATISTICAL ANALYSIS;

EID: 0347362763     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jppr2003334260     Document Type: Article

References (68)

1. Miller LG. Herbal medicines. Arch Intern Med 1998; 158: 2200-11.
2. Gill G, Leese G. Alternative medicine and diabetes. Diabet Med 2001; 18: 943.
3. Kristoffersen S, Atkin P, Shenfield G. Use of alternative medicines on Sydney's north shore. Aust J Hosp Pharm 1997; 27: 367-72.
4. Annonymous. Complementary medicines a major cost for elderly. Aust Pharmacist 1999; 18: 581.
5. MacLennan A, Wilson DH, Taylor A. Prevalence and cost of alternative medicine in Australia. Lancet 1996; 347: 569-73.
6. Shenfield G, Atkin P, Kristoffersen S. Alternative medicine: an expanding health industry. Med J Aust 1997: 19: 538-41.
7. Shenfield G. What should we be doing about complementary therapies? Curr Ther 1999: August: 7-11.
8. Angell M, Kassirer J. Alternative medicines - the risks of untested and unregulated remedies. N Engl J Med 1998; 339: 839-41.
9. Gori M, Campbell RK. Natural products and diabetes treatment. Diabetes Educ 1998; 24: 201-8.
10. Drew A, Myers S. Safety issues in herbal medicines: implications for the health professions. Med J Aust 1997; 166: 538-41.
11. Fugh-Berman A. Drug-herb interactions. Lancet 2000; 355: 134-8.
12. Fugh-Berman A, Ernst E. Herb-drug interactions: a review and assessment of report reliability. Br J Clin Pharmacol 2001; 52: 587-95.
13. Izzo A, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001; 61: 2163-75.
14. Chow R. Adverse reactions and complementary medicines. Aust Med 2001; 5 February: 8.
15. D'Arcy P. Adverse drug reactions and interactions with herbal medicines, part 1: adverse reactions. Adverse Drug React Toxicol Rev 1991; 10: 189-208.
16. D'Arcy P. Adverse reactions and interactions with herbal medicines, part 2: drug interactions. Adverse Drug React Toxicol Rev 1993; 12: 147-62.
17. Mantyranta T, Hemminki E, Koskela K. Use of alternative drugs in Finland. Pharmacoepidemiol Drug Saf 1999; 8: 23-9.
18. Eisenberg DM, Davis RB, Ettner S, Appel SM, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280: 1569-75.
19. Wandell PE, Brorsson B, Aberg H. Drug use in patients with diabetes. Diab Care 1996; 19: 992-4.
20. Ryan E, Pick M, Marceau C. Use of alternative medicines in diabetes mellitus. Diabet Med 2001; 218: 242-5.
21. Astin J, Pelletier K, Marie A, Haskell W. Complementary, and alternative medicine use among elderly persons: one-year analysis of a Blue Shield Medicare supplement. J Gerontol Series A-Biol Sciences and Med Sciences 2000; 55A: M4-M9.
22. Egede L, Xiaobou Y, Zheng D, Silverstein M. The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diab Care 2002; 25: 324-9.
23. Thomas K, Nicholl J, Coleman P. Use and expenditure on complementary medicine in England: a population based survey. Complement Ther Med 2001; 9: 2-11.
24. Dello Buono M, Urciuoli O, Marietta P, Padoani W, De Leo D. Alternative medicine in a sample of 655 community-dwelling elderly. J Psychosom Res 2001; 50: 147-54.
25. Mahabir D, Gulliford M. Use of medicinal plants for diabetes in Trinidad and Tobago. Am J Pub Health 1997; 1: 174-9.
26. Hunt L, Arar N, Akana L. Herbs, prayer and insulin. Use of medical and alternative treatments by a group of Mexican American diabetes patients. J Fam Pract 2000; 49: 216-23.
27. Leung J, Dzankic S, Manku K, Yuan C. The prevalence and predictors of the use of alternative medicine in presurgical patients in five Californian hospitals. Anesth Analg 2001; 93: 1062-8.
28. Nilsson M, Trehn G, Asplund K. Use of complementary and alternative medicine remedies in Sweden. A population-based longitudinal study within the northern Sweden MONICA Project. Multinational monitoring of trends and determinants of cardiovascular disease. J Int Med 2001; 250: 225-33.
29. Yeh G, Eisenberg DM, Davis RB, Phillips RS. Use of complementary and alternative medicine among persons with diabetes mellitus: results of a national survey. Am J Pub Health 2002; 92: 1648-52.
30. Davis T, Knuiman M, Kendall P, Vu H, Davis W. Reduced pulmonary function and its associations in type 2 diabetes, the Fremantle Diabetes Study. Diab Res Clin Pract; 50 (suppl. 2): S153-S159.
31. Davis T, Zimmet P, Davis W, Bruce D, Fida S. Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study. Diabet Med 2000; 17: 667-74.
32. Davis TM, Clifford RM, Davis WA. Effect of insulin therapy on quality of life in type 2 diabetes mellitus: The Fremantle Diabetes Study. Diab Res Clin Pract 2001; 52: 63-71.
33. Bruce D, Harrington N, Davis W, Davis T. The Fremantle Diabetes Study. Dementia and its associations in type 2 diabetes mellitus: the Fremantle Diabetes Study. Diab Res Clin Pract 2001; 53 (suppl. 3): S165-S172.
34. Glauber H. Adverse metabolic effect of omega-3 fatty acids in non-insulin dependent diabetes mellitus. Ann Intern Med 1988: 663-8.
35. Malasanos T, Stacpoole P. Biological effects of omega-3 fatty acids in diabetes mellitus. Diab Care 1991; 14: 1160-79.
36. Perharic L, Shaw D, Colbridge M. Toxicological problems resulting from exposure to traditional remedies and food supplements. Drug Saf 1994; 11: 284-94.
37. Perharic L, Shaw D, Murray V. Toxic effects of herbal medicine and food supplements. Lancet 1993; 342: 180-1.
38. Silagy C, Neli A. A meta-analysis of the effect of garlic on blood pressure. J Hypertens 1994; 12: 463-8.
39. Stevinson C, Pittler MH, Ernst E. Garlic for treating hypercholesterolemia: a meta analysis of randomised clinical trials. Ann Intern Med 2000; 133: 420-9.
40. Maxwell SR. Antioxidant vitamin supplements; update of their potential benefits and possible risks. Drug Saf 1999; 21: 253-66.
41. Mooradain A. Selected vitamins and minerals in diabetes. Diabetes Care 1994; 17: 646-65.
42. Duntas L, Kemmer T, Vorberg B. Administration of d-alpha-tocopherol in patients with insulin-dependent diabetes mellitus. Curr Ther Res 1996; 57: 682-90.
43. Barclay T, Tsourounis C. Glucosamine. Ann Pharmacother 1998; 32: 574-9.
44. Da Camara C, Dowles G. Glucosamine sulfate for osteoarthritis. Ann Pharmacother 1998; 32: 580-7.
45. Anderson R, Cheng N, Bryden N, Polansky M, Cheng N, Chi J. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 1997; 46: 1786-91.
46. Mahdi G. Chromium deficiency might contribute to insulin resistance, type 2 diabetes mellitus, dyslipidaemia, and atherosclerosis. Diabet Med 1996; 13: 389-91.
47. Kleinjnen J, Knipschild P. Ginkgo biloba. Lancet 1992; 340: 1136-9.
48. Kleinjnen J, Knipschild P. Ginkgo biloba for cerebral insufficieny. Br J Clin Phamacol 1992; 34: 352-8.
49. Diamond B, Shiflett S, Feiwel N, Matheis R, Noskin O, Richards J, et al. Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys Med Rehabil 2000; 81: 668-78.
50. Thomas K, Carr J, Westlake I. Use of non-orthodox and conventional health care in Great Britain. BMJ 1991; 302: 207-10.
51. Sleight P. The HOPE Study (Heart Outcomes Prevention Evaluation). J Renin Angiotensin Aldosterone Syst 2000; 1: 18-20.
52. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20.536 high-risk individuals: a randomized placebo-controlled trial. Lancet 2002; 360: 23-33.
53. Gogugen JM, Leiter LA. Alternative therapy: the role of selected minerals, vitamins, fiber, and herbs in treating hyperglycaemia. In: Gerstein HC, Haynes RB, editors. Evidence-based diabetes care. Hamilton: BC Decker Inc; 2001. p. 293-322.
54. Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocok N, et al. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med 1993; 328: 1747-52.
55. O'Rourke M. Determining the efficacy of glucosamine and chondroitin for osteoarthritis. Nurse Pract 2001; 26: 49-52.
56. Chan T. Interaction between warfarin and danshen (Salvia miltiorrhiza). Ann Pharmacother 2001; 35: 501-4.
57. Heck A, DeWitt B, Lukes A. Potential interactions between alternative therapies and waffarin. Am J Health-Syst Pharm 2000; 57: 1221-7.
58. Smolinske S. Dietary supplement-drug interactions. J Am Med Womens Assoc 1999; 54: 191-2, 195.
59. De Smet P, D'Arcy P. Drug interactions with herbal and other non-orthodox remedies. In: Mechanisms of drug interactions. Berlin: Springer: 1996.
60. Ernst E. Second thoughts about safety of St John's wort. Lancet 1999; 354: 2014-6.
61. Mueller B, Scott M, Sowinski K, Prag K. Noni juice (morinda citrifolia): hidden potential for hyperkalemia? Am J Kidney Dis 2000; 35: 310-12.
62. Walker J, Wynne H. Review: the frequency and severity of adverse drug reactions in elderly people. Age Ageing 1994; 23: 255-9.
63. Salom I, Davis K. Prescribing for older patients; how to avoid toxic drug reactions. Geriatrics 1995; 50: 37-40.
64. Beijer H, de Blaey C. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24: 46-54.
65. Ang-Lee M, Moss J, Yuan C. Herbal medicines and perioperative care. JAMA 2001; 286: 208-16.
66. Szeto PC, Semple SJ, Roughead EE. A study of complementary medicine advertising in Australia. Aust Pharmacist 2002; 21: 762-67.
67. Anonymous. Complementary medicines reform package. MediScene Newsletter 1999; May 1999: 3.
68. Australian Medical Association. AMA (WA) call for stronger powers for TGA. AMA (WA): 1 May, 2003. Available from: 〈 www.amawa.com.au/media/release_2003_05_01.asp〉.